
  
    
      
        
        Gastric_NNP adenocarcinoma_NN (_( GC_NNP )_) is_VBZ one_CD of_IN the_DT most_RBS common_JJ
        malignant_JJ diseases_NNS in_IN China_NNP ._. Although_IN the_DT GC_NNP has_VBZ been_VBN
        declined_VBN in_IN its_PRP$ mortality_NN rate_NN ,_, it_PRP remains_VBZ the_DT leading_VBG
        cause_NN of_IN cancer-related_JJ deaths_NNS in_IN this_DT country_NN (_( Parkin_NNP et_CC
        al_NN ._. ,_, 1992_CD ;_: World_NNP Health_NNP Organization_NNP ,_, 1994_CD ;_: Nomura_NNP A_DT ,_,
        1996_CD )_) ._. Gastric_NNP carcinogenesis_NNS is_VBZ considered_VBN as_IN a_DT multistage_NN
        progressive_JJ process_NN ._. The_DT early_JJ indicator_NN for_IN the_DT subject_JJ
        predisposed_JJ to_TO GC_NNP is_VBZ abnormal_JJ hyperproliferation_NN of_IN gastric_JJ
        epithelial_NN cells_NNS ,_, such_JJ as_IN chronic_JJ atrophic_JJ gastritis_NNS (_( CAG_NNP )_) ,_,
        DYS_NNP and_CC intestinal_NN metaplasia_NN (_( IM_NNP )_) ,_, which_WDT have_VBP been_VBN
        considered_VBN as_IN precancerous_JJ lesions_NNS of_IN GC_NNP (_( You_PRP et_CC al_NN ._. ,_, 1993_CD ;_:
        Correa_NNP P_NN ,_, 1992_CD )_) ._. However_RB ,_, the_DT information_NN for_IN the_DT mechanism_NN
        of_IN gastric_JJ carcinogenesis_NNS is_VBZ very_RB limited_JJ ._.
        The_DT growth_NN and_CC metastasis_NNS of_IN tumors_NNS depend_VBP on_IN the_DT
        development_NN of_IN an_DT adequate_JJ blood_NN supply_NN via_IN angiogenesis_NNS ._.
        Recent_JJ studies_NNS indicate_VBP that_IN the_DT inducible_JJ nitric_JJ oxide_NN
        synthase_NN (_( iNOS_NN )_) ,_, vascular_NN endothelial_NN growth_NN factor_NN (_( VEGF_NNP )_)
        and_CC tumor_NN suppressor_NN p_NN 53_CD are_VBP fundamental_JJ play-makers_JJ of_IN the_DT
        angiogenic_JJ process_NN (_( Ambs_NNP et_CC al_NN ._. ,_, 1994_CD ;_: Jekins_NNP et_CC al_NN ._. ,_, 1995_CD ;_:
        Forrester_NNP et_CC al_NN ._. ,_, 1996_CD ;_: Chiarugi_NNP et_CC al_NN ._. ,_, 1998_CD )_) ._. iNOS_NN is_VBZ one_CD
        of_IN the_DT isoforms_NNS of_IN nitric_JJ oxide_NN synthase_NN that_IN catalyzes_NNS the_DT
        formation_NN of_IN nitric_JJ oxide_NN ,_, a_DT regulator_NN of_IN vascular_NN
        permeability_NN ._. VEGF_NNP is_VBZ a_DT dimeric_JJ glycoprotein_NN and_CC has_VBZ
        specific_JJ mitogenic_JJ activity_NN for_IN endothelial_NN cells_NNS ._.
        Over-expression_NNP of_IN iNOS_NN and_CC VEGF_NNP could_MD induce_VB angiogenesis_NNS
        in_IN tumors_NNS ._. P_NN 53_CD suppresses_NNS angiogenesis_NNS by_IN down-regulating_JJ
        VEGF_NNP and_CC iNOS_NN ._. Mutant_NNP p_NN 53_CD potentiates_NNS protein_NN kinase_NN C_NNP
        induction_NN of_IN VEGF_NNP expression_NN (_( Zhang_NNP et_CC al_NN ._. ,_, 2000_CD )_) ._. In_IN a_DT
        tumorigenicity_NN model_NN using_VBG human_JJ fibroblast_NN cells_NNS ,_, the_DT loss_NN
        of_IN wild-type_JJ p_NN 53_CD and_CC transfection_NN of_IN activated_VBN ras_NNS led_VBN to_TO
        increased_VB VEGF_NNP expression_NN (_( Devavrata_NNP et_CC al_NN ._. ,_, 1995_CD )_) ._.
        Transient_NNP transfection_NN of_IN wild-type_JJ p_NN 53_CD and_CC of_IN v-src_JJ has_VBZ
        been_VBN found_VBN to_TO exert_VB opposing_VBG effects_NNS on_IN human_JJ VEGF_NNP gene_NN
        promoter_NN activity_NN in_IN human_JJ glioblastoma_NN and_CC transformed_VBN
        human_JJ fetal_JJ kidney_NN cells_NNS (_( Devavrata_NNP et_CC al_NN ._. ,_, 1995_CD )_) ._. However_RB ,_,
        because_IN wild-type_JJ p_NN 53_CD did_VBD not_RB repress_NNS hypoxia-induced_JJ
        transcription_NN of_IN the_DT VEGF_NNP gene_NN in_IN stably_RB transfected_JJ human_JJ
        colorectal_NN carcinoma_NN and_CC human_JJ hepatoblastoma_NN cells_NNS with_IN an_DT
        inducible_JJ p_NN 53_CD -_: estrogen-receptor_JJ fusion_NN protein_NN expression_NN
        system_NN (_( Ambs_NNP et_CC al_NN ._. ,_, 1998_CD )_) ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN there_EX
        is_VBZ a_DT need_NN for_IN caution_NN in_IN interpreting_VBG p_NN 53_CD function_NN on_IN the_DT
        basis_NN of_IN cells_NNS transiently_RB overexpressing_VBG this_DT protein_NN ._.
        Nevertheless_RB ,_, mutant_JJ p_NN 53_CD has_VBZ been_VBN correlated_JJ with_IN increased_VBN
        VEGF_NNP expression_NN in_IN human_JJ lung_NN cancer_NN (_( Ambs_NNP et_CC al_NN ._. ,_, 1994_CD )_) ,_,
        and_CC colorectal_NN cancer_NN (_( Ambs_NNP et_CC al_NN ._. ,_, 1999_CD )_) by_IN
        immunohistochemical_JJ staining_VBG of_IN surgical_JJ specimens_NNS ._. It_PRP has_VBZ
        been_VBN reported_VBN that_DT dysfunction_NN of_IN the_DT p_NN 53_CD /_NN MDM-_NNP 2_CD pathway_NN can_MD
        be_VB found_VBN in_IN more_JJR than_IN two-thirds_NNS of_IN angiosarcomas_NNS ;_: thus_RB ,_,
        mutant_JJ p_NN 53_CD influences_VBZ the_DT development_NN of_IN angiosarcoma_NN not_RB
        only_RB by_IN affecting_VBG growth_NN and_CC apoptosis_NNS control_VBP but_CC also_RB by_IN
        up-regulating_JJ VEGF_NNP (_( Chinrugi_NNP et_CC al_NN ._. ,_, 1998_CD )_) ._. We_PRP hypothesized_VBN
        that_IN alterations_NNS of_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP expression_NN may_MD
        contribute_VB to_TO gastric_JJ carcinogenesis_NNS and_CC influence_VB the_DT
        clinical_JJ behavior_NN of_IN GC_NNP via_IN angiogenesis_NNS ._. The_DT correlation_NN
        of_IN expression_NN of_IN p_NN 53_CD ,_, VEGF_NNP and_CC iNOS_NN and_CC clinical_JJ features_NNS
        in_IN gastric_JJ carcinogenesis_NNS ,_, however_RB ,_, has_VBZ not_RB been_VBN well_RB
        characterized_VBN ._.
        To_TO characterize_VB the_DT changes_NNS of_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP
        expression_NN in_IN human_JJ gastric_JJ carcinogenesis_NNS ,_, the_DT present_JJ
        study_NN was_VBD undertaken_VBN to_TO determine_VB the_DT protein_NN level_NN of_IN p_NN 53_CD ,_,
        iNOS_NN and_CC VEGF_NNP in_IN normal_JJ tissues_NNS and_CC the_DT tissues_NNS with_IN
        different_JJ severities_NNS of_IN lesions_NNS of_IN CSG_NNP ,_, CAG_NNP ,_, DYS_NNP ,_, IM_NNP and_CC GC_NNP
        with_IN and_CC without_IN lymph_NN node_NN metastasis_NNS from_IN surgically_RB
        resected_JJ human_JJ GC_NNP and_CC gastric_JJ biopsies_NNS from_IN symptom-free_JJ
        subjects_NNS ._. The_DT subjects_NNS were_VBD from_IN Linzhou_NNP and_CC nearby_JJ county_NN
        Huixian_NNP in_IN Henan_NNP province_NN ,_, the_DT high-incidence_JJ area_NN for_IN GC_NNP
        in_IN northern_JJ China_NNP ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Patients_NNS
          The_DT present_JJ investigation_NN included_VBD 55_CD randomly_RB
          selected_VBN GC_NNP patients_NNS and_CC 60_CD symptom-free_JJ subjects_NNS from_IN
          the_DT mass_NN survey_NN in_IN the_DT high-incidence_JJ area_NN for_IN GC_NNP ._.
          Fifty-five_NNP GC_NNP patients_NNS were_VBD performed_VBN gastric_JJ cancer_NN
          surgery_NN at_IN the_DT Linzhou_NNP People_NNPS 's_POS Hospital_NNP (_( n_NN =_SYM 26_CD )_) and_CC The_DT
          Second_NNP Affiliated_NNP Hospital_NNP of_IN Henan_NNP Medical_NNP University_NNP (_( n_NN
          =_SYM 29_CD )_) from_IN 1996_CD to_TO 1998_CD ._. Before_IN surgery_NN ,_, none_NN of_IN the_DT
          patients_NNS received_VBD any_DT kinds_NNS of_IN chemical_NN or_CC radiation_NN
          therapy_NN ._. The_DT median_JJ age_NN of_IN the_DT patients_NNS was_VBD 61_CD years_NNS (_( 30_CD
          ~_NN 77_CD years_NNS )_) ._. Cancer_NN specimens_NNS were_VBD classified_VBN based_VBN on_IN
          TNM_NNP as_IN stage_NN T_NN 1_CD (_( 19_CD patients_NNS ,_, 35_CD %_NN )_) ,_, T_NN 2_CD (_( 14_CD patients_NNS ,_,
          25_CD %_NN )_) ,_, T_NN 3_CD (_( 12_CD patients_NNS ,_, 22_CD %_NN )_) and_CC T_NN 4_CD (_( 10_CD patients_NNS ,_, 18_CD %_NN )_) ._.
          The_DT tumors_NNS were_VBD histologically_RB graded_JJ as_IN
          well-differentiated_JJ (_( 15_CD patients_NNS ,_, 27_CD %_NN )_) ,_,
          moderate-differentiated_JJ (_( 14_CD patients_NNS ,_, 25_CD %_NN )_) and_CC
          poorly-differentiated_JJ (_( 26_CD patients_NNS ,_, 47_CD %_NN )_) ._. Of_IN the_DT 55_CD
          patients_NNS ,_, 35_CD occurred_VBD local_JJ lymph_NN node_NN metastasis_NNS (_( 64_CD %_NN )_) ._.
          Gastric_NNP biopsies_NNS were_VBD taken_VBN from_IN 60_CD symptom-free_JJ subjects_NNS
          who_WP volunteered_VBD to_TO participate_VB in_IN a_DT routine_JJ endoscopic_JJ
          screening_NN for_IN esophageal_NN and_CC gastric_JJ cancer_NN in_IN Huixian_NNP ,_,
          China_NNP ._. No_DT selection_NN process_NN was_VBD involved_VBN ._. Of_IN the_DT 60_CD
          subjects_NNS examined_VBD ,_, there_EX were_VBD 35_CD males_NNS and_CC 25_CD females_NNS ._.
          The_DT median_JJ age_NN of_IN the_DT subjects_NNS was_VBD 59_CD years_NNS (_( 28_CD ~_NN 70_CD
          years_NNS )_) ._. The_DT biopsies_NNS were_VBD taken_VBN each_DT from_IN the_DT pylorus_JJ of_IN
          the_DT stomach_NN from_IN each_DT subject_NN ._.
        
        
          Tissue_NNP processing_NN
          All_DT the_DT surgically_RB resected_JJ specimens_NNS and_CC biopsy_NN
          samples_NNS were_VBD fixed_VBN with_IN 10_CD %_NN neutral_JJ formalin_NN ,_, embedded_VBN
          with_IN paraffin_NN ,_, and_CC serially_RB sectioned_JJ at_IN 5_CD μm_NN ._. The_DT
          sections_NNS were_VBD mounted_VBN onto_IN the_DT histostick-coated_JJ slides_NNS ._.
          Four_CD or_CC five_CD adjacent_JJ ribbons_NNS were_VBD collected_VBN for_IN
          histopathological_JJ analysis_NN (_( hematoxylin_NN and_CC eosin_NN stain_VB )_)
          and_CC for_IN immunohistochemical_JJ staining_VBG ._.
        
        
          Histopathological_NNP Analysis_NNP
          Histopathological_NNP diagnosis_NN for_IN gastric_JJ epithelia_NN was_VBD
          made_VBN according_VBG to_TO cellular_JJ morphological_JJ changes_NNS and_CC
          tissue_NN architecture_NN using_VBG previously_RB established_VBN criteria_NNS
          (_( Wang_NNP ,_, et_CC al_NN ._. ,_, 1994_CD ;_: You_PRP ,_, et_CC al_NN ._. ,_, 1993_CD )_) ._. In_IN brief_JJ ,_, CSG_NNP :_:
          an_DT inflammation_NN manifested_JJ by_IN mild_JJ lymphocyte_NN and_CC
          plasma-cell_JJ infiltration_NN ;_: CAG_NNP :_: glandular_NN morphology_NN
          disappeared_VBD partially_RB or_CC completely_RB absent_JJ in_IN the_DT mucosa_NN
          and_CC replaced_VBN by_IN connective_JJ tissue_NN ,_, inter-glandular_JJ space_NN
          was_VBD infiltrated_VBN mainly_RB by_IN plasma_NN cells_NNS and_CC lymphocytes_NNS ;_:
          DYS_NNP :_: characterized_VBN by_IN nuclear_JJ atypia_NN with_IN or_CC without_IN
          architectural_JJ abnormalities_NNS in_IN the_DT gastric_JJ epithelium_NN ,_,
          but_CC without_IN invasion_NN ;_: IM_NNP :_: confirmed_VBN by_IN the_DT presence_NN of_IN
          goblet_NN cells_NNS in_IN gastric_JJ mucosa_NN ;_: adenocarcinoma_NN (_( AC_NNP )_) :_:
          invasion_NN of_IN neoplastic_JJ gastric_JJ cells_NNS through_IN the_DT basement_NN
          membrane_NN ._.
        
        
          Immunohistochemical_NNP staining_VBG
          Anti-p_NNP 53_CD antibody_NN is_VBZ a_DT monoclonal_NN mouse_NN anti-serum_JJ
          against_IN p_NN 53_CD of_IN human_JJ origin_NN ,_, and_CC recognizes_VBZ both_DT
          wild-type_JJ and_CC mutant_JJ p_NN 53_CD (_( Ab-_NNP 6_CD ,_, Oncogene_NNP Science_NNP ,_,
          Manhasset_NNP ,_, NY_NNP )_) ._. Anti-i_NNP NOS_NNP antibody_NN is_VBZ a_DT monoclonal_NN mouse_NN
          anti-serum_JJ against_IN the_DT C-_NNP terminal_NN domain_NN of_IN iNOS_NN of_IN human_JJ
          origin_NN (_( sc-_NN 7271_CD ,_, Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Inc_NNP ._. ,_, Santa_NNP
          Cruz_NNP ,_, CA_NNP )_) ._. Anti-_NNP VEGF_NNP antibody_NN is_VBZ a_DT polyclonal_NN rabbit_NN
          anti-serum_JJ against_IN VEGF_NNP of_IN human_JJ origin_NN and_CC recognizes_VBZ an_DT
          amino-terminal_JJ epitope_NN found_VBD in_IN VEGF_NNP 121_CD ,_, 165_CD ,_, 189_CD and_CC
          206_CD (_( Ab-_NNP 2_CD ,_, Oncogene_NNP Science_NNP ,_, Manhasset_NNP ,_, NY_NNP )_) ._. The_DT
          avidin-biotin-peroxidase_JJ complex_JJ method_NN was_VBD used_VBN for_IN the_DT
          immunostaining_VBG of_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP ._. In_IN brief_JJ ,_, after_IN
          dewaxing_VBG ,_, inactivating_VBG endogenous_JJ peroxidase_NN activity_NN and_CC
          blocking_VBG cross-reactivity_JJ with_IN normal_JJ serum_NN (_( Vectastain_NNP
          Elite_NNP Kit_NNP ;_: Vector_NNP ,_, Burlingame_NNP ,_, CA_NNP )_) ,_, the_DT sections_NNS were_VBD
          incubated_JJ overnight_JJ at_IN 4_CD □_NN with_IN a_DT diluted_VBN solution_NN of_IN the_DT
          primary_JJ antibodies_NNS (_( 1_CD :_: 1000_CD for_IN p_NN 53_CD ,_, 1_CD :_: 200_CD for_IN iNOS_NN and_CC
          1_CD :_: 100_CD for_IN VEGF_NNP )_) ._. Location_NNP of_IN the_DT primary_JJ antibodies_NNS was_VBD
          achieved_VBN by_IN subsequent_JJ application_NN of_IN a_DT biotinylated_JJ
          anti-primary_JJ antibody_NN ,_, an_DT avidin-biotin_JJ complex_JJ
          conjugated_JJ to_TO horseradish_NN peroxidase_NN ,_, and_CC
          diaminobenzidine_NN (_( Vectastain_NNP Elite_NNP Kit_NNP ,_, Vector_NNP ,_,
          Burlingame_NNP ,_, CA_NNP )_) ._. The_DT slides_NNS were_VBD counter-stained_JJ by_IN
          hematoxylin_NN ._. Negative_JJ controls_NNS were_VBD established_VBN by_IN
          replacing_VBG the_DT primary_JJ antibody_NN with_IN PBS_NNP and_CC normal_JJ mouse_NN
          or_CC rabbit_NN serum_NN ._. Known_VBN immunostaining-positive_JJ slides_NNS
          were_VBD used_VBN as_IN positive_JJ controls_NNS ._.
          Specific_JJ staining_VBG for_IN each_DT protein_NN was_VBD categorized_VBN as_IN
          either_DT positive_JJ or_CC negative_JJ based_VBN on_IN the_DT presence_NN of_IN
          brown-color_JJ staining_VBG ._. More_JJR than_IN 10_CD %_NN cells_NNS positively_RB
          stained_JJ were_VBD graded_JJ as_IN positive_NN ._. Clear_NNP staining_VBG for_IN
          nuclei_NN (_( p_NN 53_CD )_) ,_, cytoplasm_NN and_CC cell_NN membrane_NN (_( VEGF_NNP and_CC iNOS_NN )_)
          was_VBD the_DT criterion_NN for_IN a_DT positive_JJ reaction_NN (_( Wang_NNP et_CC
          al_NN ._. ,_, 1994_CD )_) ._. All_DT the_DT immunostaining_VBG slides_NNS were_VBD observed_VBN by_IN
          two_CD pathologists_NNS (_( L_NNP D_NNP Wang_NNP and_CC L_NNP H_NNP Jiao_NNP )_) ._. The_DT slides_NNS with_IN
          different_JJ diagnosis_NN by_IN two_CD pathologists_NNS were_VBD read_VBN again_RB
          (_( less_JJR than_IN 5_CD %_NN )_) ,_, until_IN the_DT agreed_NN diagnosis_NN was_VBD made_VBN ._.
        
        
          Statistical_NNP Analysis_NNP
          The_DT X_NNP 2_CD test_NN was_VBD used_VBN for_IN the_DT percentage_NN of_IN samples_NNS
          with_IN positive_JJ stain_VB ._. Spearman_NNP correlation_NN test_NN and_CC linear_JJ
          tendency_NN test_NN were_VBD used_VBN for_IN the_DT correlation_NN between_IN
          positive_JJ rates_NNS and_CC different_JJ severities_NNS of_IN lesions_NNS (_( p_NN
          <_NN 0_CD ._. 05_CD was_VBD considered_VBN significant_JJ )_) ._.
        
      
      
        Results_NNS
        Histopathologically_NNP ,_, all_PDT the_DT 55_CD surgically-resected_JJ
        gastric_JJ specimens_NNS were_VBD confirmed_VBN as_IN adenocarcinoma_NN ._. Of_IN the_DT
        55_CD GC_NNP patients_NNS ,_, 11_CD cases_NNS occurred_VBD the_DT invasion_NN within_IN
        sub-mucosa_JJ ,_, 44_CD with_IN whole-muscle_JJ layer_NN ._. Of_IN the_DT 60_CD
        biopsy-samples_JJ examined_VBD ,_, 10_CD were_VBD diagnosed_VBN as_IN normal_JJ ,_, 15_CD as_IN
        CSG_NNP ,_, 9_CD as_IN CAG_NNP ,_, 16_CD as_IN IM_NNP with_IN CAG_NNP ,_, and_CC 10_CD as_IN DYS_NNP (_( Table_NNP
        1_LS )_) ._.
        The_DT positive_JJ immunostaining_VBG for_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP was_VBD
        observed_VBN in_IN the_DT gastric_JJ epithelial_NN cells_NNS and_CC cancer_NN cells_NNS
        with_IN different_JJ rates_NNS in_IN the_DT lesions_NNS of_IN CAG_NNP ,_, DYS_NNP ,_, IM_NNP and_CC GC_NNP ._.
        But_CC ,_, the_DT positive_JJ immunostaining_VBG for_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP was_VBD
        not_RB observed_VBN in_IN normal_JJ gastric_JJ epithelial_NN tissue_NN and_CC CSG_NNP ._.
        Figure_NN 1_CD ,_, 2_CD and_CC 3_CD shows_VBZ the_DT representative_NN of_IN p_NN 53_CD ,_, iNOS_NN and_CC
        VEGF_NNP immunostaining_VBG in_IN GC_NNP ._. p_NN 53_CD immunoreactivity_NN was_VBD located_VBN
        in_IN the_DT nuclei_NN ,_, VEGF_NNP and_CC iNOS_NN immunoreactivity_NN were_VBD located_VBN
        mainly_RB in_IN the_DT cytoplasm_NN and_CC cell_NN membrane_NN ._. iNOS_NN
        immunostaining_VBG was_VBD confirmed_VBN by_IN Western_NNP Blot_NNP on_IN part_NN of_IN
        iNOS_NN positive_JJ and_CC negative_JJ slides_NNS (_( three_CD slides_NNS for_IN each_DT )_) ,_,
        and_CC consistent_JJ results_NNS were_VBD obtained_VBN for_IN iNOS_NN
        immunohistochemistry_NN and_CC Western_NNP Blot_NNP (_( data_NNS not_RB shown_VBN )_) ._. The_DT
        positive_JJ immunostaining_VBG rate_NN for_IN p_NN 53_CD was_VBD very_RB low_JJ in_IN CAG_NNP ,_,
        and_CC slightly_RB increased_VBN in_IN IM_NNP and_CC DYS_NNP ,_, and_CC significantly_RB
        increased_VBN in_IN GC_NNP (_( Table_NNP 1_LS )_) ._. Similar_JJ results_NNS were_VBD observed_VBN in_IN
        iNOS_NN and_CC VEGF_NNP (_( Table_NNP 1_LS )_) ._. P_NN 53_CD positive_JJ immunosatining_VBG rate_NN
        in_IN well-differentiated_JJ GC_NNP was_VBD lower_JJR than_IN that_DT in_IN
        poorly-differentiated_JJ GC_NNP (_( p_NN =_SYM 0_CD ._. 012_CD ,_, Table_NNP 2_LS )_) ._. iNOS_NN
        positive_JJ staining_VBG was_VBD similar_JJ among_IN the_DT GC_NNP with_IN different_JJ
        degree_NN of_IN differentiation_NN ._. Although_IN VEGF_NNP immunostaining_VBG
        rate_NN in_IN poorly-differentiated_JJ GC_NNP was_VBD higher_JJR than_IN in_IN
        well-differentiated_JJ GC_NNP ,_, the_DT difference_NN was_VBD not_RB significant_JJ
        (_( Table_NNP 2_LS )_) ._.
        iNOS_NN positive_JJ immunostaining_VBG rate_NN in_IN the_DT cases_NNS with_IN deep_JJ
        invasion_NN of_IN GC_NNP (_( through_IN muscle_NN layers_NNS )_) was_VBD higher_JJR than_IN in_IN
        those_DT with_IN superficial_JJ invasion_NN (_( within_IN submucosa_NN )_) ,_, but_CC ,_,
        the_DT difference_NN was_VBD not_RB significant_JJ (_( Table_NNP 3_LS )_) ._. P_NN 53_CD and_CC VEGF_NNP
        immunostaining_VBG was_VBD similar_JJ in_IN GC_NNP patients_NNS with_IN superficial_JJ
        and_CC deep_JJ invasion_NN ._.
        iNOS_NN immunosatining_VBG rate_NN in_IN the_DT cases_NNS with_IN lymph_NN node_NN
        metastasis_NNS was_VBD higher_JJR than_IN that_DT in_IN those_DT without_IN lymph_NN node_NN
        metastasis_NNS (_( p_NN =_SYM 0_CD ._. 014_CD ,_, Table_NNP 4_LS )_) ._. However_RB ,_, there_EX was_VBD no_DT
        difference_NN observed_VBD for_IN p_NN 53_CD and_CC VEGF_NNP between_IN the_DT cases_NNS with_IN
        and_CC without_IN lymph_NN node_NN metastasis_NNS ._.
        P_NN 53_CD immunostaining_VBG rate_NN in_IN the_DT cases_NNS with_IN TNM_NNP grade_NN T_NN 1_CD
        was_VBD lower_JJR than_IN that_DT in_IN those_DT with_IN TNM_NNP grade_NN T_NN 2_CD ,_, T_NN 3_CD and_CC T_NN 4_CD
        (_( T_NN 1_CD :_: T_NN 3_CD ,_, p_NN =_SYM 0_CD ._. 023_CD ;_: T_NN 1_CD :_: T_NN 4_CD ,_, p_NN =_SYM 0_CD ._. 012_CD )_) ._. Similar_JJ results_NNS were_VBD
        observed_VBN in_IN VEGF_NNP (_( T_NN 1_CD :_: T_NN 2_CD and_CC T_NN 2_CD :_: T_NN 3_CD ,_, p_NN =_SYM 0_CD ._. 015_CD ;_: T_NN 1_CD :_: T_NN 4_CD ,_, p_NN =_SYM
        0_CD ._. 014_CD ;_: T_NN 2_CD :_: T_NN 4_CD ,_, p_NN =_SYM 0_CD ._. 01_CD ,_, Table_NNP 5_LS )_) ._. However_RB ,_, there_EX was_VBD no_DT
        difference_NN for_IN iNOS_NN immunostaining_VBG between_IN the_DT cases_NNS with_IN
        different_JJ TNM_NNP stages_NNS ._.
        A_DT higher_JJR coincidental_JJ expression_NN of_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP
        in_IN GC_NNP was_VBD observed_VBN ._. Of_IN the_DT 55_CD cases_NNS examined_VBD ,_, there_EX were_VBD 20_CD
        cases_NNS showing_VBG positive_JJ staining_VBG both_DT for_IN p_NN 53_CD and_CC iNOS_NN
        (_( 36_CD %_NN )_) ,_, 23_CD cases_NNS showing_VBG negative_JJ staining_VBG for_IN both_DT p_NN 53_CD and_CC
        iNOS_NN (_( 42_CD %_NN )_) (_( p_NN =_SYM 0_CD ._. 005_CD ,_, Table_NNP 6_CD )_) ,_, 19_CD cases_NNS showing_VBG positive_JJ
        staining_VBG both_DT for_IN p_NN 53_CD and_CC VEGF_NNP (_( 35_CD %_NN )_) and_CC 18_CD cases_NNS showing_VBG
        negative_JJ for_IN both_DT p_NN 53_CD and_CC VEGF_NNP (_( 33_CD %_NN )_) (_( p_NN =_SYM 0_CD ._. 01_CD ,_, Table_NNP 7_CD )_) ._.
        The_DT correlations_NNS were_VBD significant_JJ ._.
      
      
        Discussion_NNP
        An_DT interesting_JJ observation_NN in_IN this_DT study_NN was_VBD that_IN the_DT
        immunoreactivity_NN of_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP occurred_VBD in_IN the_DT
        early_JJ stage_NN of_IN gastric_JJ carcinogenesis_NNS ._. The_DT positive_JJ
        immunostaining_VBG cells_NNS were_VBD invariably_RB associated_VBN with_IN cell_NN
        proliferate_VBP activity_NN ._. With_IN the_DT lesions_NNS progressed_VBD from_IN
        normal_JJ to_TO CSG_NNP to_TO CAG_NNP to_TO IM_NNP to_TO DYS_NNP ,_, and_CC to_TO GC_NNP ,_, the_DT positive_JJ
        immunostaining_VBG rates_NNS for_IN p_NN 53_CD ,_, iNOS_NN and_CC VEGF_NNP increased_VBD
        significantly_RB ,_, the_DT increasing_VBG tendency_NN for_IN p_NN 53_CD ,_, iNOS_NN and_CC
        VEGF_NNP had_VBD a_DT good_JJ linear_JJ correlation_NN with_IN lesions_NNS
        progression_NN ._. The_DT present_JJ results_NNS indicated_VBD that_DT p_NN 53_CD protein_NN
        accumulation_NN and_CC increased_VBN expression_NN of_IN iNOS_NN and_CC VEGF_NNP may_MD
        be_VB important_JJ molecular_JJ events_NNS involved_VBN in_IN the_DT early_JJ stage_NN
        of_IN gastric_JJ carcinogenesis_NNS ._.
        Another_DT interesting_JJ observation_NN was_VBD that_IN ,_, a_DT high_JJ
        coincidental_JJ positive_JJ immunostaining_VBG rates_NNS for_IN p_NN 53_CD and_CC iNOS_NN
        (_( 36_CD %_NN )_) and_CC p_NN 53_CD and_CC VEGF_NNP (_( 35_CD %_NN )_) was_VBD observed_VBN (_( Table_NNP 6_CD and_CC 7_CD )_) ._.
        This_DT result_NN was_VBD consistent_JJ with_IN the_DT findings_NNS in_IN human_JJ lung_NN
        and_CC colon_NN carcinomas_NNS (_( Ambs_NNP et_CC al_NN ._. ,_, 1999_CD )_) ._. Although_IN p_NN 53_CD
        antibody_NN used_VBN in_IN this_DT study_NN could_MD not_RB differentiate_VB
        wild-type_JJ p_NN 53_CD from_IN mutant_JJ p_NN 53_CD ,_, previous_JJ studies_NNS have_VBP
        indicated_VBN that_DT p_NN 53_CD protein_NN detected_VBN by_IN immunohistochemistry_NN
        seems_VBZ to_TO representative_NN most_RBS mutant_JJ p_NN 53_CD ._. Accumulation_NNP of_IN
        p_NN 53_CD is_VBZ an_DT indicator_NN for_IN a_DT loss_NN of_IN p_NN 53_CD tumor_NN suppressor_NN
        function_NN ._. Both_DT mutations_NNS and_CC protein-protein_JJ interactions_NNS
        can_MD cause_VB a_DT p_NN 53_CD accumulation_NN (_( Wang_NNP ,_, et_CC al_NN ._. ,_, 1994_CD )_) ._.
        Considering_VBG that_DT p_NN 53_CD protein_NN accumulation_NN was_VBD correlated_JJ
        with_IN poorly-differentiation_JJ and_CC T_NN 2_CD ,_, T_NN 3_CD and_CC T_NN 4_CD TNM_NNP stage_NN of_IN
        GC_NNP ,_, we_PRP concluded_VBD that_DT p_NN 53_CD protein_NN accumulation_NN in_IN this_DT
        study_NN may_MD lead_VB to_TO the_DT loss_NN of_IN cell_NN proliferation_NN control_NN
        and_CC inhibition_NN for_IN iNOS_NN and_CC VEGF_NNP ,_, possibly_RB because_IN of_IN p_NN 53_CD
        gene_NN mutation_NN ._. Thus_RB ,_, the_DT high_JJ coincidental_JJ expression_NN of_IN
        iNOS_NN and_CC VEGF_NNP and_CC p_NN 53_CD protein_NN accumulation_NN may_MD be_VB important_JJ
        events_NNS to_TO enhance_VB gastric_JJ carcinogenesis_NNS and_CC poorly_RB
        clinical_JJ features_NNS and_CC may_MD be_VB useful_JJ biomarkers_NNS to_TO assess_VB
        risk_NN for_IN the_DT development_NN of_IN GC_NNP ._. Recent_JJ studies_NNS on_IN Japanese_NNP
        GC_NNP patients_NNS have_VBP showed_VBN that_WDT increased_VBN expression_NN of_IN VEGF_NNP
        and_CC p_NN 53_CD protein_NN accumulation_NN are_VBP associated_VBN with_IN
        intra-tumoral_JJ angiogenesis_NNS (_( Takeuchi_NNP ,_, et_CC al_NN ._. ,_, 2000_CD ;_: Saito_NNP ,_,
        et_CC al_NN ._. ,_, 1999_CD )_) and_CC poor_JJ prognosis_NN (_( Skatani_NNP ,_, et_CC al_NN ._. ,_, 2000_CD ;_:
        Ikeguchi_NNP ,_, et_CC al_NN ._. ,_, 2000_CD ;_: Maeda_NNP ,_, et_CC al_NN ._. ,_, 1998_CD )_) ._. Rajnkova_NNP
        reported_VBD that_WDT increased_VBN expression_NN of_IN iNOS_NN may_MD promote_VB
        gastric_JJ cancer_NN progression_NN by_IN providing_VBG a_DT selective_JJ growth_NN
        advantage_NN to_TO tumor_NN cells_NNS with_IN non-functioning_JJ p_NN 53_CD ._.
        (_( Rajnkova_NNP ,_, et_CC al_NN ._. ,_, 2001_CD )_)
        The_DT third_JJ observation_NN in_IN this_DT study_NN was_VBD that_WDT increased_VBN
        expression_NN of_IN iNOS_NN and_CC VEGF_NNP and_CC p_NN 53_CD protein_NN accumulation_NN
        occurred_VBD with_IN a_DT high_JJ frequency_NN in_IN gastric_JJ biopsy_NN samples_NNS
        with_IN IM_NNP ._. IM_NNP ,_, which_WDT may_MD be_VB defined_VBN as_IN the_DT replacement_NN of_IN
        gastric_JJ mucosa_NN by_IN glands_NNS which_WDT have_VBP the_DT histological_JJ ,_,
        histochemical_JJ ,_, and_CC physiological_JJ characteristics_NNS of_IN the_DT
        small_JJ intestine_NN ,_, has_VBZ been_VBN strongly_RB associated_VBN with_IN stomach_NN
        cancer_NN ._. The_DT present_JJ results_NNS demonstrated_VBN that_IN IM_NNP was_VBD a_DT
        unstable_JJ stage_NN with_IN active_JJ molecular_JJ changes_NNS ,_, and_CC further_JJ
        analysis_NN to_TO compare_VB these_DT changes_NNS with_IN normal_JJ small_JJ
        intestine_NN will_MD provides_VBZ more_JJR information_NN for_IN the_DT
        significance_NN of_IN IM_NNP in_IN gastric_JJ carcinogenesis_NNS ._.
        Finally_RB ,_, the_DT present_JJ study_NN demonstrated_VBN that_IN the_DT
        positive_JJ immunostaining_VBG rates_NNS of_IN iNOS_NN was_VBD correlated_JJ well_RB
        with_IN GC_NNP lymph_NN node_NN metastasis_NNS ,_, increased_VBN expression_NN of_IN VEGF_NNP
        and_CC p_NN 53_CD protein_NN accumulation_NN was_VBD related_VBN with_IN TNM_NNP stages_NNS
        and_CC GC_NNP differentiation_NN ._. These_DT findings_NNS indicate_VBP that_DT p_NN 53_CD ,_,
        iNOS_NN and_CC VEGF_NNP may_MD be_VB useful_JJ biomarkers_NNS for_IN GC_NNP
        aggressiveness_NN ._. The_DT molecular_JJ basis_NN for_IN the_DT observed_VBN
        expression_NN of_IN iNOS_NN and_CC VEGF_NNP and_CC p_NN 53_CD protein_NN accumulation_NN
        and_CC their_PRP$ roles_NNS in_IN the_DT progression_NN of_IN gastric_JJ pre-cancerous_JJ
        lesions_NNS and_CC angeogenesis_NNS requires_VBZ to_TO be_VB carefully_RB
        investigated_VBN in_IN the_DT laboratory_NN and_CC follow-up_JJ studies_NNS ._.
      
      
        Abbreviations_NNP
        The_DT abbreviations_NNS used_VBN are_VBP :_: CSG_NNP ,_, chronic_JJ superficial_JJ
        gastritis_NNS ;_: CAG_NNP ,_, chronic_JJ atrophic_JJ gastritis_NNS ;_: DYS_NNP ,_, dysplasia_NN ;_:
        GC_NNP ,_, gastric_JJ adenocarcinoma_NN ;_: iNOS_NN ,_, inducible_JJ nitric_JJ oxide_NN
        synthase_NN ;_: IM_NNP ,_, intestinal_NN metaplasia_NN ;_: VEGF_NNP ,_, vascular_NN
        endothelial_NN growth_NN factor_NN ._.
      
    
  
